Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular allergy guidelines: a practical treatment algorithm.

Leonard Bielory1

  • 1UMDNJ, Asthma & Allergy Research Center, Immuno-Ophthalmology Service, New Jersey Medical School, Newark, New Jersey, USA. bielory@umdnj.edu

Drugs
|July 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the immune-microbial axis in chronic ocular surface disease.

Current opinion in allergy and clinical immunology·2025
Same author

Bridging diagnostic gaps in anterior ocular inflammatory surface diseases.

Current opinion in allergy and clinical immunology·2025
Same author

From innovation to implementation: strengthening anterior ocular inflammatory surface diseases diagnostics through global health policy.

Current opinion in allergy and clinical immunology·2025
Same author

The Link Between Allergic Rhinitis and Keratoconus: A Call for Greater Awareness, Early Intervention, and Future Ocular Surface Diagnostic Tools.

The journal of allergy and clinical immunology. In practice·2024
Same author

The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist.

Current opinion in allergy and clinical immunology·2024
Same author

Ocular surface disorders: office procedures for the allergist/clinical immunologist.

Current opinion in allergy and clinical immunology·2024
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Understanding ocular allergies, like seasonal allergic conjunctivitis (SAC) and atopic keratoconjunctivitis (AKC), involves recognizing immune cell activity. This knowledge aids in developing better treatments for allergic eye diseases.

Area of Science:

  • Immunology
  • Ophthalmology
  • Allergy Research

Background:

  • Ocular allergy treatment necessitates understanding immune system components and conjunctival interactions.
  • The immune response involves Th2 lymphocytes, mast cells, eosinophils, fibroblasts, and epithelial/endothelial cells.
  • Ocular allergic disorders (SAC, PAC, VKC, GPC, AKC) are part of a broader atopic disease spectrum.

Purpose of the Study:

  • To elucidate the spectrum of ocular allergic disorders.
  • To detail the immunopathological and molecular mechanisms involved.
  • To inform therapeutic strategies for allergic conjunctivitis.

Main Methods:

  • Immunopathological techniques
  • Molecular immunological techniques
  • Comparative analysis of disease severity (SAC, PAC, VKC, AKC)

Related Experiment Videos

Main Results:

  • Minimal changes in SAC; more pronounced in PAC due to longer allergen exposure.
  • Chronic forms (VKC, AKC) show persistent immune cell activation, mast cell switching, corneal pathology, and fibrosis.
  • Pathological changes correlate with disease duration and severity.

Conclusions:

  • Advances in understanding ocular allergy mechanisms enable targeted interventional therapies.
  • Improved knowledge supports developing guidelines for better ocular health in allergic patients.
  • Future treatments can move beyond symptomatic relief to address underlying immunopathology.